Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
The Tohoku Journal of Experimental Medicine|June 6, 2014
Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter surveyRyu Watanabe, Tomonori Ishii, Hiroko Kobayashi, et al.
Medicine|November 15, 2019
Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case reportTomoyuki Asano, Shuzo Sato, Makiko Yashiro Furuya, et al.
Medicine|August 30, 2019
Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitisNaoki Matsuoka, Hideko Kozuru, Tomohiro Koga, et al.
Arthritis Research & Therapy|September 14, 2017
Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still's diseaseTomoyuki Asano, Hiroshi Furukawa, Shuzo Sato, et al.
Nature Communications|May 19, 2018
Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel diseaseMasayoshi Ohkuro, Jun-Dal Kim, Yoshikazu Kuboi, et al.
Annals of the Rheumatic Diseases|July 11, 2020
Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutationTomoko Matsuda, Naotomo Kambe, Yoko Ueki, et al.
Medicine|December 19, 2018
Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitisKiyoshi Migita, Yoshiro Horai, Hideko Kozuru, et al.
Modern Rheumatology|March 3, 2016
Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study GroupYasuhiko Hirabayashi, Yasuhiko Munakata, Masayuki Miyata, et al.
Fukushima Journal of Medical Science|March 29, 2023
Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort studyMasayuki Miyata, Yasuhiko Hirabayashi, Yasuhiko Munakata, et al.
Pageof 17